Sutro Biopharma, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
STRO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
111 Oyster Point Blvd., South San Francisco, CA

There are no Buy or Sell transactions made by insiders since 4/22/2024

Sutro Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
William J. Newell CEO, Director $1.4M Mar 5, 2025
Anne E. Borgman Chief Medical Officer $941K Feb 28, 2025
Jane Chung Chief Executive Officer, Director $574K Apr 4, 2025
Edward C. Albini Cfo And Secretary $535K Mar 5, 2025
Trevor Hallam Pres. Rsrch & Cf. Sctific Ofcr $508K Apr 14, 2023
Arturo Molina Chief Medical Officer $354K Mar 4, 2022
Shabbir Anik Chief Technical Ops. Officer $274K Mar 3, 2023
David Pauling Chief Admin. Ofcr. & GC $262K Apr 4, 2025
Linda A. Fitzpatrick Chief People & Comm. Officer $259K Mar 5, 2025
Venkatesh Srinivasan Chief Tech Op Officer $222K Apr 11, 2025
Hans-Peter Gerber Chief Scientific Officer $204K Apr 4, 2025
Barbara Leyman Chief Business Dev. Officer $115K Apr 4, 2025
Daniel H. Petree Director $106K Jun 6, 2024
Nicki Vasquez Chief Port. Strat & Alnce Ofcr $71.3K Jan 29, 2024
Brunilda Shtylla Chief Business Officer $41.2K Aug 28, 2023
Michael Dybbs Director Jun 6, 2024
Joseph M. Lobacki Director Jun 6, 2024
Jon Marc Wigginton Director Jun 6, 2024
Shalini Sharp Director Jun 6, 2022
Heidi Hunter Director Jun 6, 2024
John G. Freund Director Jun 6, 2024
James P. Panek Director Jun 6, 2024
Connie Matsui Director Jun 6, 2024
Sukhi Jagpal Director Aug 8, 2024

Recent Insider Transactions by Companies or Individuals for Sutro Biopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.